🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

16 recruiting trials

for Irritable Bowel Syndrome - Diarrhoea

Efficacy of Rifaximin With NAC in IBS-D NCT06727422Phase 21 site📍 Los Angeles Mark Pimentel, MD · Tests: rifaximin 66mg + N-acetylcysteine 560mg three times daily, RNIB21 containing rifaximin 132mg + N-acetylcysteine 560mg t… Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome NCT07000383NA1 site📍 Ho Chi Minh City University Medical Center Ho Chi Minh City (UMC) · Tests: Gelsectan, Antispasmodic Agent A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) NCT07519395Phase 2114 sites📍 Anniston📍 Guntersville📍 Mobile GlaxoSmithKline · Tests: Placebo, Camlipixant A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D NCT06247046Phase 32 sites📍 Wuxi📍 Binzhou Guangzhou Zhiyi Biotechnology Co., Ltd. · Tests: Live SK08 powder, Placebo Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome NCT07114055Phase 2, Phase 31 site📍 Dhaka Md. Hazrat Ali · Tests: ebastine, Placebo Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome NCT06737666Phase 11 site📍 Beijing Xiyuan Hospital of China Academy of Chinese Medical Sciences · Tests: Tong-Xie-Yao-Fang Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial NCT07581756NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: rTMS group, sham device Kimchi Powder on Gut Health NCT07749092NA1 site📍 Yangsan Pusan National University Yangsan Hospital · Tests: Kimchi power, Placebo Lf-rTMS Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea NCT06757491NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Repetitive Transcranial Magnetic Stimulation, Sham (No Treatment) Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator NCT06684470EARLY Phase 11 site📍 Jacksonville Mayo Clinic · Tests: Mirtazapine, Placebo Fecal Microbiota Transplantation for IBS NCT05776914Phase 21 site📍 Rochester Madhusudan (Madhu) Grover, MBBS · Tests: Donor Fecal Microbiota Transplantation, Autologous Fecal Microbiota Transplantation Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome NCT07168434Phase 310 sites📍 Braga📍 Lisbon📍 Barcelona Biocodex · Tests: Saccharomyces Boulardii 250 MG, Placebo 250 mg Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome NCT06681012NA12 sites📍 Leuven📍 Bobigny📍 Rouen Devintec Sagl · Tests: Gelsectan®, Placebo Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) NCT06960369Phase 11 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: rTMS combined with Live Probiotic tablet, rTMS combined placebo, shamrTMS combined with Live Probiotic tablet, shamrTMS… Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress NCT07656623NA1 site📍 Hanoi Institute of Gastroenterology and Hepatology, Vietnam · Tests: Ecologic Barrier, Ecologic Barrier A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) NCT07545759Phase 289 sites📍 Mesa📍 Anaheim📍 Lancaster Eli Lilly and Company · Tests: LY3537031, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy